| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5590890 | Multiple Sclerosis and Related Disorders | 2017 | 10 Pages |
Abstract
Sulbutiamin appears to be effective in treating fatigue in MS; particularly in patients who were on some DMT, but not on those who were not. It is well-tolerated by all. This observation may encourage further evaluations of the efficacy of sulbutiamine on fatigue in MS.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Genetics
Authors
Serhan Sevim, Hakan KaleaÄası, Bahar TaÅdelen,